"While the current regulatory system for biotechnology products effectively protects the health and the environment, advances in science and technology since 1992 have been altering the product landscape," John P Holdren, the White House science adviser, and three other senior White House officials said in a blog post on Thursday.
They said, the complexity of the current system "can make it difficult for the public to understand how the safety of biotechnology products is evaluated, and navigating the regulatory process for these products can be unduly challenging, especially for small companies."
The administration said it would accept public input and hoped to complete the initial update to the regulatory framework in a year.
The existing system - known as the coordinated framework - was announced in 1986 and updated in 1992, at a time when GM crops were not yet being marketed. The framework parceled out responsibility for regulating crops and some other products made by genetic engineering among three agencies - the Agriculture Department, the Environmental Protection Agency and the Food and Drug Administration.
Critics of biotechnology crops have long said that the current system is too lax, and they will no doubt push for tougher regulations.
But some executives in the biotechnology industry and academic scientists have been saying the regulations are unnecessarily tough, making it too costly and too difficult for many academic researchers and small companies to bring genetically engineered crops to market.
One purpose of the review is to "prevent unnecessary barriers to future innovation and competitiveness," according to a memo sent by the White House to the federal agencies involved.
But people on both sides hoping for big changes might be disappointed. An administration official said the focus in the first year would be on clarifying which products or product areas each agency is responsible for rather than changing the regulations.
A task force of government agencies will be set up to do that. It will also be charged with coming up with a better system for keeping abreast of technological changes. In that future phase, changes to regulations might be considered, according to the White House memo.
The review concerns regulations for products made by genetic engineering that are introduced into the environment, like crops, animals and microbes. It would not affect the regulation of pharmaceuticals.
More than 90 per cent of the corn, soybeans and cotton grown in the United States have foreign genes inserted into their DNA to make them resistant to herbicides or insects or both.
The existing framework has some aspects that seem unusual. Genetically engineered animals, for instance, are regulated as animal drugs. That means the veterinary division of the FDA. is charged with determining whether genetically engineered mosquitoes can be released in the Florida Keys to help combat dengue fever.
The Agriculture Department regulates GM crops under rules governing plant pests like insects and pathogens. Companies are now developing crops that do not fall under the department's narrow jurisdiction.
GREEN MODIFICATION
- Obama administration says it will accept public inputs; hopes to complete the initial update to the regulatory framework in a year
- The existing system, announced in 1986, was updated in 1992, at a time when GM crops were not yet being marketed
- About 90% of the corn, soybeans and cotton grown in the US have foreign genes inserted into their DNA
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)